107results about How to "Satisfied level" patented technology

A neurological control system for modulating activity of any component or structure comprising the entirety or portion of the nervous system, or any structure interfaced thereto, generally referred to herein as a “nervous system component.” The neurological control system generates neural modulation signals delivered to a nervous system component through one or more neuromodulators to control neurological state and prevent neurological signs and symptoms. Such treatment parameters may be derived from a neural response to previously delivered neural modulation signals sensed by one or more sensors, each configured to sense a particular characteristic indicative of a neurological or psychiatric condition.

A neurological control system for modulating activity of any component or structure comprising the entirety or portion of the nervous system, or any structure interfaced thereto, generally referred to herein as a “nervous system component.” The neurological control system generates neural modulation signals delivered to a nervous system component through one or more neuromodulators, comprising intracranial (IC) stimulating electrodes and other actuators, in accordance with treatment parameters. Such treatment parameters may be derived from a neural response to previously delivered neural modulation signals sensed by one or more sensors, each configured to sense a particular characteristic indicative of a neurological or psychiatric condition.

A process and method for collecting, validating, storing, scoring and presenting consumer satisfaction feedback on the delivery of goods and services sold to consumers by service providers. The feedback of consumers is collected by using electronic forms to capture consumer responses to questions on surveys. Consumer feedback is scored over at least three recent periods of time including the past twelve months, the past six months and past three months. The customer satisfaction scores are presented on a plurality of advertising medias.

A ventilation controller including at least one humidity sensor for controlling the humidity of a room. The ventilation controller incorporates a housing sized and shaped to replace, or be placed in, a standard electrical junction box. Circuitry in the controller receives data from the sensor(s). The controller automatically switches on power to an exhaust fan when either the humidity exceeds a manually set humidity level and/or a rapid increase in humidity is observed. When a plurality of sensors is employed, the humidity level from a first sensor is compared by logic circuitry to the humidity levels detected at a reference sensor(s). When the humidity at the first sensor exceeds the humidity at the reference sensor(s), the ventilation controller switches on power to the exhaust fan.

An apparatus that facilitates the creation of circumferential lesions in body tissue. The apparatus includes a first probe having a loop structure that supports electrodes or other operative elements against the body tissue and a second probe with an expandable push structure that may be used to urge the loop structure against body tissue.

A multi-source electronic vapor cigarette which overcomes the shortcomings of current devices. The device allows a user, when using the device for smoking cessation, to select different levels of nicotine at different times of the day to satisfy different levels of craving. The device holds multiple individual containers of a different liquid concentration of nicotine, flavored or not, or flavored medium only, within one device. A user can select a desired refillable container by operation of a switch to create a vapor passage from the desired container to the mouthpiece. For flavored vapor users, operation of the switch will select a container holding the desired flavor. The user can take a puff of one flavor vapor followed by another without mixing flavors within the device. The device allows any desired combination by inserting individual containers the user fills with their choice of liquid.

A flame-retardant resin composition comprises a thermoplastic resin; a flame retardant comprising a phosphorus-containing compound (A), a aromatic resin (B), and at least one flame-retardant auxiliary (C) selected from a nitrogen-containing compound and a metal salt of an inorganic acid; and at least one stabilizer auxiliary (D) selected from a compound having a functional group reactive to an active hydrogen atom and a water-repellent compound. The phosphorus-containing compound may be a phosphoric ester. The aromatic resin may be a polyphenylene sulfide-series resin or a polyphenylene oxide-series resin. The nitrogen-containing compound is a salt of an amino group-containing triazine compound with an oxygen acid, a salt of an amino group-containing triazine compound with a hydroxyl group-containing triazine compound, a polyphosphoric acid amide, a cyclic urea compound, or others. The present invention provides a flame-retardant resin composition which has been flame-retarded without using a halogen-containing flame retardant.

A digital camera system that implements a method for providing image processing customized according to an identified person. The method includes: capturing an input digital image of a scene; identifying at least one particular person in the input digital image by analyzing signals received from an electronic device associated with the particular person; retrieving image processing preferences, wherein the retrieved image processing preferences are associated with one of the identified particular persons; processing the input digital image to form a modified digital image according to retrieved image processing preferences; and storing the modified digital image in a storage memory.

The present invention relates to solid dosage forms of cannabinoid pharmaceutical formulations comprising a solvated cannabinoid for buccal or sublingual administration, and methods of making and using the same.

The invention provides a quality manager for use in a digital content delivery system. The digital content delivery system comprises a plurality of user devices, a source unit connected through a communication network to the user devices for delivering digital content to the user devices in the form of bursts of content. The quality manager is connected to the user devices and adapted to receive notifications therefrom, each notification received from a given user device identifying a burst received by the given user device and including a quality indicator related to the quality of the received burst. The quality manager is further adapted to select a set of bursts among the bursts identified by the notifications, based on predefined rules comprising a rule related to the quality indicator included in the notifications, and for sending a request for retransmission of the selected bursts to the source unit.

A vehicular heating system comprising a passenger compartment air-conditioner and a radiative heater which heats a foot area of a passenger, said vehicular heating system detecting foot vent heat which said foot vent air flow has and controlling said passenger compartment air-conditioner and said radiative heater in accordance with that heat.

Chimeric parainfluenza viruses (PIVs) are provided that incorporate a PIV vector genome or antigenome modified to encode a chimeric glycoprotein incorporating one or more heterologous antigenic domains, fragments, or epitopes of a second, antigenically distinct HPIV. These chimeric viruses are infectious and attenuated in humans and other mammals and are useful in vaccine formulations for eliciting an immune responses against one or more PIVs, and, optionally against respiratory syncytial virus (RSV). Also provided are isolated polynucleotide molecules and vectors incorporating a chimeric PIV genome or antigenome which includes a HPIV vector genome or antigenome combined or integrated with one or more heterologous genome segment(s) encoding one or more antigenic determinant(s) of a heterologous PIV to encode a chimeric glycoprotein. In preferred aspects of the invention, the chimeric virus is attenuated for use as a vaccine agent by additional mutations or nucleotide modifications introduced into the chimeric genome or antigenome.

A method for allocating radio resource to one or more first UEs by a femto BS, includes: acquiring information about one or more second UEs which are located within a cell coverage of the femto BS but served by the macro BS; receiving a control channel from the macro BS; acquiring radio resource information allocated to the second UEs by the macro BS from the control channel; and allocating radio resource to the first UEs such that the allocated radio resource does not overlap with radio resource information allocated to the second UEs.

A wireless base station comprises a response vector calculation unit (561), an RSSI measuring unit (562), an MSE calculation unit (563), an FD calculation unit (564) and the like, and those units obtain an index showing communication quality of at least one of two mobile stations that are intended to be space-division multiplexed. According to the index, a control unit (80) judges the suitability of the two mobile stations for space-division multiplexing and performs space-division multiple access communication when judging suitable. The effect achieved with this construction is that the wireless base station maintains quality of communication between the wireless base station and mobile stations at a certain satisfactory level when performing space-division multiple access communication.

A rehabilitation plan for an individual with a medical condition is selected in view of physical dimensions and personal environment dimensions of the individual that can impact successful use of an instrument for treating the medical condition. Measurement results obtained from assessments of respective physical dimensions and personal environment dimensions of the individual are used to define respective diagnostics metrics, and also to generate diagnostic and goal scores for the respective metrics. A rehabilitation plan for the individual is selected in view of the diagnostic and goal scores with the intention of increasing an individual's compatibility with the plan and the likelihood of success for rehabilitation. The selection of a rehabilitation plan can include querying a database including previously prescribed rehabilitation plans indexed by physical and personal environment dimensions characteristics of respective patients that were prescribed the rehabilitation plans.

The disclosure relates to a spectacle lens comprising: a lens base member; a multi-layered anti-reflection film placed on the lens base member, and including a layer mainly made of silicon dioxide as an outermost layer; and a water-and-oil repellent layer provided in contact with the outermost layer of the multi-layered anti-reflection film, and made by using, as raw materials: at least one kind of a first fluorine-substituted alkyl group-containing organosilicon compound and a second fluorine-substituted alkyl group-containing organosilicon compound. The disclosure also relates to methods of producing a spectacle lens that is capable of retaining a sufficient water-and-oil repellency over an extended period, and having sufficient edge processability.

The present invention relates to an ink jet recording method for recording a white overlaying layer and a pattern layer on a longitudinal film base material, printed matters obtained by the recording method, and systems for realizing the recording method thereof.

Chimeric parainfluenza viruses (PIVs) incorporate a PIV vector genome or antigenome and one or more antigenic determinant(s) of a heterologous PIV or non-PIV pathogen. These chimeric viruses are infectious and attenuated in humans and other mammals and are useful in vaccine formulations for eliciting an immune responses against one or more PIVs, or against a PIV and non-PIV pathogen. Also provided are isolated polynucleotide molecules and vectors incorporating a chimeric Ply genome or antigenome which includes a partial or complete PIV vector genome or antigenome combined or integrated with one or more heterologous gene(s) or genome segment(s) encoding antigenic determinant(s) of a heterologous PIV or non-PIV pathogen.

In a loudspeaker device of the present invention, an interior space of a cabinet is parted into first and second chambers, a diaphragm on which ring-shaped magnetic boards are fixed is attached to a parting board via an edge portion, and ring-shaped fixed magnets are provided so as to face the magnetic boards, respectively. Vibration of the diaphragm vibrated by sound pressure from a speaker unit is intensified by forces of attraction of the magnets in order to reduce an acoustic stiffness of the cabinet and equivalently increase a cabinet volume, thereby realizing satisfactory bass reproduction with a small cabinet.

A resin film with pressure-sensitive adhesive layer of the invention includes a first transparent resin film, an oligomer blocking layer, and a pressure-sensitive adhesive layer laminated in this order, wherein the oligomer blocking layer is a cured layer formed by curing a composition containing a curable compound and inorganic oxide particles, the oligomer blocking layer has a thickness of 120 nm or more, the oligomer blocking layer has a refractive index difference of 0.04 or less from the pressure-sensitive adhesive layer, and an anchoring strength between the oligomer blocking layer and the pressure-sensitive adhesive layer is 1 N/25 mm or more.

The resin film with pressure-sensitive adhesive layer can prevents the oligomer blocking layer from causing interference fringes, in which even when made thin, the oligomer blocking layer satisfies the requirements including oligomer blocking properties and scratch resistance, and also has good adhesion to the pressure-sensitive adhesive layer.

Chimeric parainfluenza viruses (PIVs) are provided that incorporate a PIV vector genome or antigenome and one or more antigenic determinant(s) of a heterologous PIV or non-PIV pathogen. These chimeric viruses are infectious and attenuated in humans and other mammals and are useful in vaccine formulations for eliciting and immune responses against one or more PIVs, or against a PIV and non-PIV pathogen. Also provided are isolated polynucleotide molecules and vectors incorporating a chimeric PIV genome or antigenome which includes a partial or complete PIV vector genome or antigenome combined or integrated with one or more heterologous gene(s) or genome segment(s) encoding antigenic determinant(s) of a heterologous PIV or non-PIV pathogen. In preferred aspects of the invention, chimeric PIV incorporate a partial or complete human PIV vector genome or antigenome combined with one or more heterologous gene(s) or genome segment(s) from a heterologous PIV or non-PIV pathogen, wherein the chimeric virus is attenuated for use as a vaccine agent by any of a variety of mutations and nucleotide modifications introduced into the chimeric genome or antigenome.